MIM
XGN icon

Monashee Investment Management’s Exagen XGN Stock Holding History

Monashee Investment Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-172,170
Closed -$3.01M – 481
2021
Q1 		$3.01M Buy
+172,170
New +$3.07M 0.46% 57
2019
Q4 		– Sell
-115,000
Closed -$1.78M – 131
2019
Q3 		$1.78M Buy
+115,000
New +$1.86M 0.81% 44

Other funds holding XGN

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Monashee Investment Management's XGN Position: Q2 2021 in Review

Monashee Investment Management sold out of Exagen (XGN) in Q2 2021, closing a stake of 172,170 shares — an estimated $3.01M sold.

Monashee Investment Management first reported a position in XGN in Q3 2019 and held it in 2 quarters. The position peaked at $3.01M in Q1 2021. 54 funds tracked by Wall St. Rank hold XGN as of Q2 2021.

  • Monashee Investment Management reported no remaining Exagen position as of Q2 2021 after selling out during the quarter.
  • Monashee Investment Management sold 172,170 Exagen shares in Q2 2021, an estimated $3.01M.
  • Monashee Investment Management first reported a position in Exagen in Q3 2019 and held it in 2 quarters.
  • Monashee Investment Management's Exagen position peaked at $3.01M in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Exagen as of Q2 2021.

Based on Monashee Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.